Stay updated on Safety Efficacy HMI-203 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.

Latest updates to the Safety Efficacy HMI-203 in MPS II Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe term Mucopolysaccharidosis, MPS-II was added to the page's keywords/MeSH terms. The term Mucopolysaccharidosis type 2 was removed.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 of the page; this appears to be a backend/version change rather than substantive alterations to study information.SummaryDifference0.1%

- Check25 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision 3.4.2 was added and a government-funding operating-status notice was removed, representing a minor site update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedThe page adds a glossary and makes minor edits to labels and revision/version text (e.g., QC history labels and version identifiers).SummaryDifference0.2%

Stay in the know with updates to Safety Efficacy HMI-203 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.